These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25363528)

  • 1. Role of interleukin-21 in HBV infection: friend or foe?
    Li Y; Tang L; Hou J
    Cell Mol Immunol; 2015 May; 12(3):303-8. PubMed ID: 25363528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 Plays a Crucial Role in HBV Infection.
    Lan T; Chang L; Wu L; Yuan YF
    J Clin Transl Hepatol; 2015 Dec; 3(4):271-6. PubMed ID: 26807383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-21 responses in patients with chronic hepatitis B.
    Li J; Ren W; Ma W; Zhang J; Shi J; Qin C
    J Interferon Cytokine Res; 2015 Feb; 35(2):134-42. PubMed ID: 25243706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
    Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-35: a potential therapeutic target for controlling hepatitis B virus infection.
    Xiang XG; Xie Q
    J Dig Dis; 2015 Jan; 16(1):1-6. PubMed ID: 25476593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 21 Reinvigorates the Antiviral Activity of Hepatitis B Virus (HBV)-Specific CD8+ T Cells in Chronic HBV Infection.
    Tang L; Chen C; Gao X; Zhang W; Yan X; Zhou Y; Guo L; Zheng X; Wang W; Yang F; Liu G; Sun J; Hou J; Li Y
    J Infect Dis; 2019 Feb; 219(5):750-759. PubMed ID: 30260401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research advances in the role of interleukin-21 in chronic hepatitis B virus infection].
    Ding R; Ma SW
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):469-73. PubMed ID: 27465956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
    Zhou Y; Zhang H; Li Y
    Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepant Clinical Significance of CD28
    Shen XH; Xu P; Yu X; Song HF; Chen H; Zhang XG; Wu MY; Wang XF
    Viral Immunol; 2018 Oct; 31(8):548-558. PubMed ID: 30117787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.
    Shoraka S; Mohebbi SR; Hosseini SM; Hosseini Razavi A; Hatami Y; Sharifian A; Rostami-Nejad M; Asadzadeh Aghdaei H; Zali MR
    Microb Pathog; 2019 Mar; 128():263-267. PubMed ID: 30639626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosis.
    Cheng LS; Liu Y; Jiang W
    World J Gastroenterol; 2015 Oct; 21(38):10721-31. PubMed ID: 26478664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBcAg-specific IL-21-producing CD4+ T cells are associated with relative viral control in patients with chronic hepatitis B.
    Li L; Liu M; Cheng LW; Gao XY; Fu JJ; Kong G; Feng X; Pan XC
    Scand J Immunol; 2013 Nov; 78(5):439-46. PubMed ID: 23957859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
    Zhang Q; Yang L; Liu S; Zhang M; Jin Z
    Front Immunol; 2021; 12():645835. PubMed ID: 34177894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL13-mediated recruitment of intrahepatic CXCR5
    Li Y; Tang L; Guo L; Chen C; Gu S; Zhou Y; Ye G; Li X; Wang W; Liao X; Wang Y; Peng X; Liu G; Zhang X; Sun J; Peng J; Hou J
    J Hepatol; 2020 Mar; 72(3):420-430. PubMed ID: 31610223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection.
    Jacobi FJ; Wild K; Smits M; Zoldan K; Csernalabics B; Flecken T; Lang J; Ehrenmann P; Emmerich F; Hofmann M; Thimme R; Neumann-Haefelin C; Boettler T
    J Hepatol; 2019 Jun; 70(6):1103-1113. PubMed ID: 30826436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity.
    Meng F; Zhen S; Song B
    APMIS; 2017 Aug; 125(8):743-751. PubMed ID: 28493520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alterations of IFN-γ and IL-4 of peripheral blood T cells in patients with chronic HBV infection].
    Li M; Sun X; Zhou Z; Zhang X; Jin S; Gao Y; Gao Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):240-4. PubMed ID: 26927386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic expansion of virus-specific CD8
    Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q
    Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.